Table 1: Univariate analysis of the comparing
of the exposed and the non-exposed groups at the end of follow-up period in
relation to the study
outcomes
|
Variable |
Biologics use # 73 |
Non- Biologics use #
262 |
OR*
95%
CI** |
Fisher's Exact p value P( < 0.05) |
|
Surgery No
Surgery |
20 53 |
37 223 |
2.556 1.386-4.715 |
0.0038** |
|
Opthalmologic
Sympt. No
Symptoms |
1 72 |
0 260 |
12.81 0.516-317.9 |
0.19 |
|
Dermatologic/Oral
Sympt. No
Symptoms |
3 70 |
23 237 |
0.533 0.1555-1.826 |
0.4398 |
|
Musculoskeletal
Sympt. No
Symptoms |
31 42 |
52 208 |
3.648 2.101-6.333 |
< 0.0001** |
|
Renal/Hepatobilary
sympt. No
Symptoms |
1 72 |
18 242 |
0.2245 0.02947-1.711 |
0.142 |
|
Pancreatitis
Sympt. No
Symptoms |
2 71 |
10 250 |
0.8423 0.1805-3.931 |
1.0000 |
|
Appendectomy No
Appendectomy |
7 66 |
25 235 |
1.205 0.4997-2.905 |
0.6427 |
|
Growth
Failure No
Growth Failure |
2 71 |
10 250 |
0.8423 0.1805-3.931 |
1.0000 |
|
Abscess/Fistula No
Abscess/Fistula |
19 54 |
33 227 |
2.943 1.559-5.556 |
0.0019** |
|
Infection No
Infection |
4 69 |
9 251 |
1.932 0.5781-6.460 |
0.2834 |
|
Diabetes No
Diabetes |
1 72 |
4 256 |
1.059 0.1165-9.623 |
1.0000 |
|
Stricture/Bowel/Obstruction No
Stricture/Bowel/Obstruction |
11 62 |
25 235 |
2.015 0.9419-4.313 |
0.0758 |
*Odds Ratio
**Confidence
Interval